Kaiser Permanente co-led the medical data software provider's latest round, pushing its total funding past the $170m mark.

OM1, a US-based medical data technology developer backed by automotive components manufacturer Wanxiang, completed an $85m funding round co-led by care consortium Kaiser Permanente on Friday.

Investment firms D1 Capital Partners and Breyer Capital co-led the round with Kaiser Permanente and they were joined by existing investors including General Catalyst, Polaris Partners, Scale Venture Partners, 7wire Ventures and Glikvest.

Founded in 2015, OM1 provides a software platform able to analyse real-world clinical data for medical research in numerous chronic disease…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?